The early amniocentesis study: a randomized clinical trial of early amniocentesis and midtrimester amniocentesis. II. Evaluation of procedure details and neonatal congenital anomalies

Fetal Diagn Ther. 1997 Mar-Apr;12(2):97-101. doi: 10.1159/000264440.


The present study provides detailed neonatal and congenital malformation follow-up from 695 women enrolled in a prospective randomized multicenter study comparing the safety and accuracy of early (11-12 weeks of gestation) and midtrimester amniocentesis (15-16 weeks of gestation). No differences were found for total pregnancy loss (difference 0.4%; CI -3.6 to 4.4%), obstetrical or neonatal outcome. The incidence of congenital anomalies was 2.4 and 2.6% for the early amniocentesis and midtrimester amniocentesis groups, respectively. Respiratory problems were present in 2.1 and 1.6%, respectively. Musculoskeletal problems were present in 0.9 and 2.4%, respectively. It must be emphasized that before early amniocentesis can be considered as an alternative to midtrimester amniocentesis or chorionic villus sampling, careful evaluation of any fetal effects must be considered and further large randomized trials are necessary.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniocentesis / methods*
  • Amniocentesis / statistics & numerical data
  • Female
  • Fetal Diseases / diagnosis*
  • Fetal Diseases / embryology
  • Fetus / abnormalities*
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Prospective Studies
  • Reproducibility of Results
  • Safety